Categories: News

Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference

WOBURN, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference on September 13, 2022 at 2:00 pm ET. The conference is being held on September 12 – 14, 2022 at the Lotte New York Palace Hotel.

A live webcast of the presentation and a replay will be available on the Investor Relations section of the Company’s website at IR Events & Presentations | Yield10 Bioscience, Inc.

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils for renewable diesel, PHA bioplastics and omega-3 (DHA+EPA) oils, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on TwitterFacebook and LinkedIn.

(YTEN-G)

Contacts:

Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

Staff

Recent Posts

GE HealthCare to announce second quarter 2024 results on July 31, 2024

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions…

2 hours ago

OnMed and Overtown Youth Center (OYC Miami) announce a new partnership for a unique healthcare access solution

TAMPA, Fla.--(BUSINESS WIRE)--#OYCMiami--The industry’s leading tech-enabled and human-led, health equity solution, OnMed today announced its…

2 hours ago

GE HealthCare to announce second quarter 2024 results on July 31, 2024

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions…

2 hours ago

OnMed and Overtown Youth Center (OYC Miami) announce a new partnership for a unique healthcare access solution

TAMPA, Fla.--(BUSINESS WIRE)--#OYCMiami--The industry’s leading tech-enabled and human-led, health equity solution, OnMed today announced its…

2 hours ago

Bemax, Inc. Announces Outstanding Financial Results for Fiscal Year 2024

Revenue Soars Over 600% Year-Over-Year as Company Continues Expansion and Cost Reduction EffortsDallas, Georgia--(Newsfile Corp.…

2 hours ago

CBIH: Unleashing the Potential of Cannabis for Tomorrow’s Medicine

A letter from our deskHouston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start…

2 hours ago